Assignee
ENTERIS BIOPHARMA INC
US·5 granted patents·4 pending applications·11 citations·filing 2014–2022
Top patents by PatentIndex Score
9 records- 0189US9399017B2Peptide pharmaceutical for oral deliveryENTERIS BIOPHARMA INC·Filed 2014·Granted Jul 26, 2016·10 cites·59 claims
- 0268US9457086B2Pharmaceuticals for oral deliveryENTERIS BIOPHARMA INC·Filed 2014·Granted Oct 4, 2016·1 cites·20 claims
- 0358US2016339081A1Peptide Pharmaceutical for Oral DeliveryENTERIS BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 0454US9744140B2Pharmaceuticals for oral deliveryENTERIS BIOPHARMA INC·Filed 2016·Granted Aug 29, 2017·0 cites·18 claims
- 0553US9526785B2Pharmaceuticals for oral deliveryENTERIS BIOPHARMA INC·Filed 2016·Granted Dec 27, 2016·0 cites·15 claims
- 0653US2017319502A1Pharmaceuticals for Oral DeliveryENTERIS BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 0752US2025073309A1Methods of treatment of pediatric puberty using oral formulations of leuprolideENTERIS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0838US2018049987A1Solid Oral Dosage FormsENTERIS BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 0934US9833411B2Solid oral dosage formsENTERIS BIOPHARMA INC·Filed 2016·Granted Dec 5, 2017·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when ENTERIS BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →